103 research outputs found
Gamma-Ray Telescopes (in "400 Years of Astronomical Telescopes")
The last half-century has seen dramatic developments in gamma-ray telescopes,
from their initial conception and development through to their blossoming into
full maturity as a potent research tool in astronomy. Gamma-ray telescopes are
leading research in diverse areas such as gamma-ray bursts, blazars, Galactic
transients, and the Galactic distribution of aluminum-26.Comment: 11 pages, 6 figures/ in "400 Years of Astronomical Telescopes: A
Review of History, Science and Technology", ed. B.R. Brandl, R. Stuik, & J.K.
Katgert-Merkeli (Exp. Astron. 26, 111-122 [2009]
Measurement of the flux of atmospheric muons with the CAPRICE94 apparatus
A new measurement of the momentum spectra of both positive and negative muons
as function of atmospheric depth was made by the balloon-borne experiment
CAPRICE94. The data were collected during ground runs in Lynn Lake on the
19-20th of July 1994 and during the balloon flight on the 8-9th of August 1994.
We present results that cover the momentum intervals 0.3-40 GeV/c for negative
muons and 0.3-2 GeV/c for positive muons, for atmospheric depths from 3.3 to
1000 g/cm**2, respectively. Good agreement is found with previous measurements
for high momenta, while at momenta below 1 GeV/c we find latitude dependent
geomagnetic effects. These measurements are important cross-checks for the
simulations carried out to calculate the atmospheric neutrino fluxes and to
understand the observed atmospheric neutrino anomaly.Comment: 28 pages, 13 Postscript figures, uses revtex.sty, to appear in Phys.
Rev.
Balloon Measurements of Cosmic Ray Muon Spectra in the Atmosphere along with those of Primary Protons and Helium Nuclei over Mid-Latitude
We report here the measurements of the energy spectra of atmospheric muons
and of the cosmic ray primary proton and helium nuclei in a single experiment.
These were carried out using the MASS superconducting spectrometer in a balloon
flight experiment in 1991. The relevance of these results to the atmospheric
neutrino anomaly is emphasized. In particular, this approach allows
uncertainties caused by the level of solar modulation, the geomagnetic cut-off
of the primaries and possible experimental systematics to be decoupled in the
comparison of calculated fluxes of muons to measured muon fluxes. The muon
observations cover the momentum and depth ranges of 0.3-40 GeV/c and 5-886
g/cmsquared, respectively. The proton and helium primary measurements cover the
rigidity range from 3 to 100 GV, in which both the solar modulation and the
geomagnetic cut-off affect the energy spectra at low energies.Comment: 31 pages, including 17 figures, simplified apparatus figure, to
appear in Phys. Rev.
Recommended from our members
Galactic cosmic radiation in the interplanetary space through a modern secular minimum
Recent solar conditions indicate a persistent decline in solar activity—possibly similar to thepast solar grand minima. During such periods of low solar activity, the fluxes of galactic cosmic rays(GCRs) increase remarkably, presenting a hazard for long-term crewed space missions. We used data fromthe Cosmic Ray Telescope for the Effects of Radiation (CRaTER) on the Lunar Reconnaissance Orbiter(LRO) to examine the correlation between the heliospheric magnetic field, solar wind speed, and solarmodulation potential of the GCRs through Cycle 24. We used this correlation to project observations frompast secular solar minima, including the Dalton minimum (1790–1830) and the Gleissberg minimum(1890–1920), into the next cycle. For the case of conditions similar to the Dalton (or Gleissberg) minimum,the heliospheric magnetic field could drop to 3.61 (or 4.06) nT, leading to a dose rate increase of75% (or34%). We showed that accounting for a floor in the modulation potential, invoked by the Badhwar-O'Neill2014 model, moderates the projected radiation levels in Cycle 25. We used these results to determine themost conservative permissible mission duration (PMD,290.4+37.7−35.9and 204.3+26.6−25.2days for 45-year-old maleand female astronauts, respectively) based on a 3% risk of exposure-induced death (REID) at the upper95% confidence interval in interplanetary space
Search for antihelium in cosmic rays
The Alpha Magnetic Spectrometer (AMS) was flown on the space shuttle
Discovery during flight STS-91 in a 51.7 degree orbit at altitudes between 320
and 390 km. A total of 2.86 * 10^6 helium nuclei were observed in the rigidity
range 1 to 140 GV. No antihelium nuclei were detected at any rigidity. An upper
limit on the flux ratio of antihelium to helium of < 1.1 * 10^-6 is obtained.Comment: 18 pages, Latex, 9 .eps figure
Effect of alpha-7 nicotinic acetylcholine receptor activation on beta-amyloid induced recognition memory impairment. Possible role of neurovascular function
14 Examples of How LLMs Can Transform Materials Science and Chemistry: A Reflection on a Large Language Model Hackathon
Chemistry and materials science are complex. Recently, there have been great
successes in addressing this complexity using data-driven or computational
techniques. Yet, the necessity of input structured in very specific forms and
the fact that there is an ever-growing number of tools creates usability and
accessibility challenges. Coupled with the reality that much data in these
disciplines is unstructured, the effectiveness of these tools is limited.
Motivated by recent works that indicated that large language models (LLMs)
might help address some of these issues, we organized a hackathon event on the
applications of LLMs in chemistry, materials science, and beyond. This article
chronicles the projects built as part of this hackathon. Participants employed
LLMs for various applications, including predicting properties of molecules and
materials, designing novel interfaces for tools, extracting knowledge from
unstructured data, and developing new educational applications.
The diverse topics and the fact that working prototypes could be generated in
less than two days highlight that LLMs will profoundly impact the future of our
fields. The rich collection of ideas and projects also indicates that the
applications of LLMs are not limited to materials science and chemistry but
offer potential benefits to a wide range of scientific disciplines
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
BACKGROUND: We aimed to assess the efficacy and safety of two neutralising monoclonal antibody therapies (sotrovimab [Vir Biotechnology and GlaxoSmithKline] and BRII-196 plus BRII-198 [Brii Biosciences]) for adults admitted to hospital for COVID-19 (hereafter referred to as hospitalised) with COVID-19. METHODS: In this multinational, double-blind, randomised, placebo-controlled, clinical trial (Therapeutics for Inpatients with COVID-19 [TICO]), adults (aged ≥18 years) hospitalised with COVID-19 at 43 hospitals in the USA, Denmark, Switzerland, and Poland were recruited. Patients were eligible if they had laboratory-confirmed SARS-CoV-2 infection and COVID-19 symptoms for up to 12 days. Using a web-based application, participants were randomly assigned (2:1:2:1), stratified by trial site pharmacy, to sotrovimab 500 mg, matching placebo for sotrovimab, BRII-196 1000 mg plus BRII-198 1000 mg, or matching placebo for BRII-196 plus BRII-198, in addition to standard of care. Each study product was administered as a single dose given intravenously over 60 min. The concurrent placebo groups were pooled for analyses. The primary outcome was time to sustained clinical recovery, defined as discharge from the hospital to home and remaining at home for 14 consecutive days, up to day 90 after randomisation. Interim futility analyses were based on two seven-category ordinal outcome scales on day 5 that measured pulmonary status and extrapulmonary complications of COVID-19. The safety outcome was a composite of death, serious adverse events, incident organ failure, and serious coinfection up to day 90 after randomisation. Efficacy and safety outcomes were assessed in the modified intention-to-treat population, defined as all patients randomly assigned to treatment who started the study infusion. This study is registered with ClinicalTrials.gov, NCT04501978. FINDINGS: Between Dec 16, 2020, and March 1, 2021, 546 patients were enrolled and randomly assigned to sotrovimab (n=184), BRII-196 plus BRII-198 (n=183), or placebo (n=179), of whom 536 received part or all of their assigned study drug (sotrovimab n=182, BRII-196 plus BRII-198 n=176, or placebo n=178; median age of 60 years [IQR 50-72], 228 [43%] patients were female and 308 [57%] were male). At this point, enrolment was halted on the basis of the interim futility analysis. At day 5, neither the sotrovimab group nor the BRII-196 plus BRII-198 group had significantly higher odds of more favourable outcomes than the placebo group on either the pulmonary scale (adjusted odds ratio sotrovimab 1·07 [95% CI 0·74-1·56]; BRII-196 plus BRII-198 0·98 [95% CI 0·67-1·43]) or the pulmonary-plus complications scale (sotrovimab 1·08 [0·74-1·58]; BRII-196 plus BRII-198 1·00 [0·68-1·46]). By day 90, sustained clinical recovery was seen in 151 (85%) patients in the placebo group compared with 160 (88%) in the sotrovimab group (adjusted rate ratio 1·12 [95% CI 0·91-1·37]) and 155 (88%) in the BRII-196 plus BRII-198 group (1·08 [0·88-1·32]). The composite safety outcome up to day 90 was met by 48 (27%) patients in the placebo group, 42 (23%) in the sotrovimab group, and 45 (26%) in the BRII-196 plus BRII-198 group. 13 (7%) patients in the placebo group, 14 (8%) in the sotrovimab group, and 15 (9%) in the BRII-196 plus BRII-198 group died up to day 90. INTERPRETATION: Neither sotrovimab nor BRII-196 plus BRII-198 showed efficacy for improving clinical outcomes among adults hospitalised with COVID-19. FUNDING: US National Institutes of Health and Operation Warp Speed
DIRAC: A High Resolution Spectrometer for Pionium Detection
The DIRAC spectrometer has been commissioned at CERN with the aim of
detecting atoms produced by a 24 GeV/ high intensity proton
beam in thin foil targets. A challenging apparatus is required to cope with the
high interaction rates involved, the triggering of pion pairs with very low
relative momentum, and the measurement of the latter with resolution around 0.6
MeV/. The general characteristics of the apparatus are explained and each
part is described in some detail. The main features of the trigger system,
data-acquisition, monitoring and setup performances are also given.Comment: 49 pages, 37 figures. Figures 1, 2, 5 and 28 are removed because of
size limitations imposed by hep-ex. They don't offer essential information.
Latex class file 'elsart.cls' also provide
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary.
S
- …